Structural determinants of indole amine action on in vitro insulin release.
D000813:Anilides / Q000494:pharmacology; D000818:Animals; D002934:Cinnamates / Q000494:pharmacology; D006224:Cricetinae; D003514:Cyclohexylamines / Q000494:pharmacology; D006897:Hydroxyindoleacetic Acid / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000378:metabolism*; D007329:Insulin Antagonists; D000078790:Insulin Secretion; D008297:Male; D008550:Melatonin / Q000494:pharmacology; D008784:Methysergide / Q000494:pharmacology; D010179:Pancreas / Q000187:drug effects / Q000378:metabolism*; D011863:Radioimmunoassay; D012701:Serotonin / Q000494:pharmacology; D012702:Serotonin Antagonists; D013329:Structure-Activity Relationship; D014363:Tryptamines / Q000494:pharmacology
D000813:Anilides; D002934:Cinnamates; D003514:Cyclohexylamines; D007328:Insulin; D007329:Insulin Antagonists; D012702:Serotonin Antagonists; D014363:Tryptamines; D012701:Serotonin; D006897:Hydroxyindoleacetic Acid; D008550:Melatonin; D008784:Methysergide